Tricuspid Valve Replacement Safe, Effective in Pivotal Trial
(MedPage Today) -- SAN FRANCISCO -- The investigational Evoque transcatheter tricuspid valve replacement (TTVR) prosthesis appeared safe and beneficial in initial pivotal trial data.
The major adverse event rate of 27.4% was less than the expected... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 27, 2023 Category: Cardiology Source Type: news
Mitral Valve TEER Device 'Horse Race' Draws Even Closer
(MedPage Today) -- SAN FRANCISCO -- The Pascal device remained noninferior to MitraClip for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation (DMR) in full results from the pivotal CLASP IID trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 27, 2023 Category: Cardiology Source Type: news
Small Aortic Annuli Not Inherently More Amenable to TAVR
(MedPage Today) -- SAN FRANCISCO -- One anatomic feature, typically found in women, did not make patients with severe aortic stenosis (AS) better suited for either transcatheter aortic valve replacement (TAVR) or surgery, the VIVA trial investigators... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 27, 2023 Category: Cardiology Source Type: news
Retinal Artery Occlusion Tied to Higher Risks of Death, Vascular Events
(MedPage Today) -- Credit: CoRus13
Patients with retinal artery occlusions (RAOs) had subsequent increased risks of death, stroke, and myocardial infarction (MI) over both the short and long term compared with matched controls with cataracts... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 26, 2023 Category: Cardiology Source Type: news
Tricuspid Clip Might Work for More Patients Than Thought
(MedPage Today) -- SAN FRANCISCO -- Tricuspid transcatheter edge-to-edge repair (T-TEER) performed better than anticipated in patients expected to have only a modest benefit due to more complex anatomy, the TRILUMINATE trial showed.
After receiving... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 26, 2023 Category: Cardiology Source Type: news
Targeting Collaterals During Primary PCI Disappoints in Trial
(MedPage Today) -- SAN FRANCISCO -- Pressure-controlled intermittent coronary sinus occlusion (PiCSO) for acute myocardial infarction (AMI) appeared safe but ineffective in reducing infarct size, the PiCSO-AMI-I trial showed.
Use of the device... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 26, 2023 Category: Cardiology Source Type: news
Even Less Aspirin With Ticagrelor-Based DAPT Safe After Stenting for ACS
(MedPage Today) -- SAN FRANCISCO -- For ticagrelor-based antithrombotic regimens after drug-eluting stent implantation for acute coronary syndrome (ACS), stopping aspirin within the first month appeared to be safer than continuing it in the T... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 26, 2023 Category: Cardiology Source Type: news
Drug-Coated Balloon Answers 'Embarrassing' Need for In-Stent Restenosis in U.S.
(MedPage Today) -- SAN FRANCISCO -- The Agent paclitaxel-coated balloon was better than conventional balloon angioplasty for in-stent restenosis (ISR), according to the AGENT IDE pivotal trial that will be used to support the device's case for... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
Esprit Resorbable Scaffold Triumphs for Severe PAD Below the Knee
(MedPage Today) -- SAN FRANCISCO -- The Esprit BTK drug-eluting resorbable scaffold proved safe and effective for patients with chronic limb-threatening ischemia (CLTI) and infrapopliteal artery disease, the Life-BTK randomized controlled trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
Combining TAVR, LAA Closure in Same Procedure Safe, Trial Says
(MedPage Today) -- SAN FRANCISCO -- Left atrial appendage occlusion (LAAO) at the time of transcatheter aortic valve replacement (TAVR) appeared as safe as TAVR alone, the WATCH-TAVR trial showed.
For patients with severe aortic stenosis and... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
Aortic Regurgitation Device Passes in Pivotal Trial
(MedPage Today) -- SAN FRANCISCO -- Aortic valve regurgitation treated with the investigational JenaValve Trilogy appeared safe and effective in the ALIGN AR trial.
The device met the safety benchmark, with a 26.7% rate of combined 30-day all... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
Tricuspid Regurgitation Device Passes in Pivotal Trial
(MedPage Today) -- SAN FRANCISCO -- Tricuspid valve regurgitation treated with the investigational JenaValve Trilogy appeared safe and effective in the ALIGN AR trial.
The device met the safety benchmark, with a 26.7% rate of combined 30-day... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
Using Statins With Blood Thinners Linked With Less GI Bleeding Risk
(MedPage Today) -- VANCOUVER, British Columbia -- Patients taking blood thinners who were also prescribed statins had a lower risk of gastrointestinal bleeding, no matter what type of blood thinner was used, a retrospective analysis suggested... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
Amulet vs Watchman Comparison Still Muddy Any Which Way LAA Leaks Are Defined
(MedPage Today) -- SAN FRANCISCO -- Two mainstream devices for percutaneous left atrial appendage (LAA) closure continued to lead to similar clinical outcomes in the SWISS-APERO trial.
Among patients randomized to the Amplatzer Amulet and the... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 24, 2023 Category: Cardiology Source Type: news
Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valve
(MedPage Today) -- SAN FRANCISCO -- A handful of years later, transcatheter aortic valve replacement (TAVR) still compared well against surgery in the PARTNER 3 and Evolut Low Risk trials.
PARTNER 3 appeared to show a convergence of the TAVR... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 24, 2023 Category: Cardiology Source Type: news
